Gastric Cancer: Generalities, Traditional Treatments, and Biological Therapies as New Therapeutic Options

 

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Awduron: Aguilar Murillo, Raquel, Martínez Carpio, Stefanny, Ulloa Rojas, Raquel, Valerio Villalobos, Melissa, Mora Román, Juan José
Fformat: artículo de revisión
Dyddiad Cyhoeddi:2022
Disgrifiad:Gastric cancer is one of the most frequent types worldwide. It is the fourth most common and the second most deadly. Costa Rica is the leading country where this pathology is diagnosed in Central America. Its development involves nutritional, genetic, and environmental factors, among others. Traditional treatments are based on surgery (considered first-line), radiotherapy, and chemotherapy. In recent years, work has been done on new biological therapies to improve the patients' quality of life and survival. Advances have been achieved in the field of microRNAs, in which there is a promising future. The most studied have been miR-218, miR-375, and miR-7, diminished in gastric tumors. As a complement, vaccines have been developed, including rMVHu191 and G17DT. Many have required the incorporation of adjuvants to enhance the immune response. Finally, monoclonal antibodies have been considered for distinct targets related to this disease. Of these molecules, only trastuzumab, ramucirumab, nivolumab, and pembrolizumab have approval against this illness. Although there is still a long way ahead, soon will be more available options.
Gwlad:Kérwá
Sefydliad:Universidad de Costa Rica
Repositorio:Kérwá
Iaith:Inglés
OAI Identifier:oai:kerwa.ucr.ac.cr:10669/91650
Mynediad Ar-lein:https://iarconsortium.org/iarjp/112/435/gastric-cancer-generalities-traditional-treatments-and-biological-therapies-as-new-therapeutic-options-1509/
https://hdl.handle.net/10669/91650
Allweddair:gastric cancer
Treatment
biological therapy
vaccines
microRNAs
monoclonal antibodies